openPR Logo
Press release

Pulmonary And Respiratory Drug Delivery Market 2019 Comprehensive Study On AptarGroup S. A.,Novartis, Roche,TTP plc,Hovione,Teva Pharmaceutical, OMRON Group, Catalent Pharma Solutions., Sunovion Pharmaceuticals., Cipla, GlaxoSmithKline Pharma GmbH,3M

01-28-2019 05:06 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

/ PR Agency: Data Bridge Market Research
Global Pulmonary and Respiratory Drug Delivery Market

Global Pulmonary and Respiratory Drug Delivery Market

Data Bridge Market Research Published New Report As Titled” Global Pulmonary and respiratory drug delivery Market-Industry Trends and Forecast to 2025. Pulmonary and respiratory drug delivery market report is a precise study of the Drug Delivery Devices industry which explains what the market definition, classifications, applications, engagements, and global industry trends are.

Global Pulmonary and respiratory drug delivery market report contains all the company profiles of the major players and brands. The report displays important product developments and tracks recent acquisitions, mergers and research in the Drug Delivery Devices industry by the key players. The market drivers and restraints have been explained using SWOT analysis.

Pulmonary and respiratory drug delivery market is expected to witness growth during the forecast period due to growing demand at the end user level. This report gives an edge to not only compete but also to outdo the competition.

Market Analysis:

Global pulmonary and respiratory drug delivery market is expected to reach USD 63.79 billion by 2025, from USD 38.63 billion in 2017 growing at a CAGR of 6.7% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get FREE Sample of Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-pulmonary-respiratory-drug-delivery-market

Key Developments in the Market:

• In March 2016, FDA approved V-Go, a wearable 24 hour subcutaneous insulin delivery device by Medtronic for diabetes management, which have helped diabetes treatment outcome.

• In April 2013, Bayer Healthcare launched a hormonal intrauterine device (IUD) called Skyla. The product is launched in Europe with the brand name Jaydess, and is used for the prevention of pregnancy for up to three years.

Competitors/Players: Global Pulmonary/Respiratory Drug Delivery Market

• GlaxoSmithKline Pharma GmbH
• 3M,
• AstraZeneca,
• Boehringer Ingelheim
• Philips,
• PARI,
• GF Health Products Inc.,
• Merck
• Progressive Trade Media Limited
• BeyonDevices,
• Lda,
• Aphios Corporation,
• AptarGroup S. A.
• Novartis,
• Roche,
• TTP plc,
• Hovione,
• Teva Pharmaceutical,
• OMRON Group,
• Catalent Pharma Solutions.
• Sunovion Pharmaceuticals.,
• Cipla
• among others.

Table Of Content:

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Pulmonary And Respiratory Drug Delivery Market Landscape
Part 04: Global Pulmonary And Respiratory Drug Delivery Market Sizing
Part 05: Five Forces Analysis
Part 06: Global Pulmonary And Respiratory Drug Delivery Market Segmentation By Product
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

And More…..Get Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-pulmonary-respiratory-drug-delivery-market

Competitive Analysis: Global Pulmonary and Respiratory Drug Delivery Market

The global pulmonary/respiratory drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pulmonary/respiratory drug delivery market for global, Europe, North America, Asia Pacific and South America.

Major Market Drivers and Restraints:

• Growing preference for pulmonary drug delivery as an alternate route of drug delivery

• Development of smart/digital inhalers

• Increasing respiratory diseases

• Regulatory issues

• Pricing pressure

Primary Respondents

• Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

• Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Know More Business Opportunities In Global Pulmonary And Respiratory Drug Delivery Market. Speak To Our Analyst And Gain Crucial Industry Insights That Will Help Your Business Expand Request Analyst Call at https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-pulmonary-respiratory-drug-delivery-market

Market Segmentation: Global Pulmonary/Respiratory Drug Delivery Market

The Global Pulmonary/Respiratory Drug Delivery Market is segmented based on

• Canister Type,
• Application,
• End User,
• Formulation
• Geography

By formulation the global pulmonary/respiratory drug delivery market is segmented into type and device type. Type is further sub segmented into

• suspension aerosols,
• solution aerosols and
• dry powder formulations.
• Device type metered dose inhalers (MDIS),
• dry powder inhalers (DPIS)
• nebulizers

Nebulizers are further sub segmented into

• jet nebulizers,
• ultrasonic nebulizers
• soft mist nebulizers

By canister type the global pulmonary/respiratory drug delivery market is segmented into

• plain canisters
• coated canister.

On the basis of application the global pulmonary/respiratory drug delivery market is segmented into

• chronic obstructive pulmonary disease,
• asthma,
• cystic fibrosis
• others

On the basis of end user the global pulmonary/respiratory drug delivery market is segmented into

• hospitals & clinics
• home care settings.

Based on geography, the market report covers data points for 28 countries across multiple geographies namely

• North America & South America,
• Europe,
• Asia-Pacific and,
• Middle East & Africa.

Customization of the Report

• All segmentation provided above in this report is represented at country level. All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Browser Full Report With Research Methodology at https://databridgemarketresearch.com/reports/global-pulmonary-respiratory-drug-delivery-market/

Customization of the Report: This report can be customized to meet the client’s requirements. Please connect with us (sopan.gedam@databridgemarketresearch.com), we will ensure that you get a report that suits your needs.

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary And Respiratory Drug Delivery Market 2019 Comprehensive Study On AptarGroup S. A.,Novartis, Roche,TTP plc,Hovione,Teva Pharmaceutical, OMRON Group, Catalent Pharma Solutions., Sunovion Pharmaceuticals., Cipla, GlaxoSmithKline Pharma GmbH,3M here

News-ID: 1539144 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Pulmonary

Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028. The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments